These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 15482226)
21. Activity of the ketolide antibacterial telithromycin against typical community-acquired respiratory pathogens. Felmingham D; Zhanel G; Hoban D J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():33-42. PubMed ID: 11566974 [TBL] [Abstract][Full Text] [Related]
22. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Inoue M; Kohno S; Kaku M; Yamaguchi K; Igari J; Yamanaka K Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993 [TBL] [Abstract][Full Text] [Related]
23. Macrolide resistance in Streptococci and Haemophilus influenzae. Bozdogan B; Appelbaum PC Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849 [TBL] [Abstract][Full Text] [Related]
24. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. Felmingham D J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493 [TBL] [Abstract][Full Text] [Related]
25. Geminofloxacin for the management of community-acquired respiratory tract infections. Blondeau JM; Tillotson G; Deangelis J J Chemother; 2006 Dec; 18(6):582-8. PubMed ID: 17267335 [TBL] [Abstract][Full Text] [Related]
26. [What is the importance of bacterial eradication in the treatment of respiratory tract infections?]. Gonzalo de Liria CR An Pediatr (Barc); 2004 May; 60(5):459-67. PubMed ID: 15105002 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children. Sunakawa K; Farrell DJ Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316 [TBL] [Abstract][Full Text] [Related]
32. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431 [TBL] [Abstract][Full Text] [Related]
33. PROTEKT US: results from the second year of this longitudinal surveillance study of antimicrobial resistance among respiratory tract pathogens isolated from paediatric and adult patients in the USA. Introduction. Brown SD J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i5. PubMed ID: 15352301 [No Abstract] [Full Text] [Related]
34. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility. Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352 [TBL] [Abstract][Full Text] [Related]
35. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Pfaller MA; Ehrhardt AF; Jones RN Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437 [TBL] [Abstract][Full Text] [Related]
36. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides. Sbarbaro JA Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248 [No Abstract] [Full Text] [Related]
37. Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project. García-De-Lomas J; García-Rey C; López L; Gimeno C J Antimicrob Chemother; 2002 Dec; 50 Suppl S2():21-6. PubMed ID: 12556430 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients. Zarakolu P; Unal S J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238 [No Abstract] [Full Text] [Related]
39. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Schito GC; Pesce A; Debbia EA Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761 [TBL] [Abstract][Full Text] [Related]
40. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010]. Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]